Burkina Faso vs Cape Verde: The number of people with susceptibility test result for rifampicin
Burkina Faso
67.26
in 2021
Cape Verde
69.01
in 2021
Burkina Faso rank
106th
Cape Verde rank
105th
The number of people with susceptibility test result for rifampicin over time
- Burkina Faso
- Cape Verde
How they compare
Cape Verde currently reports 69.01 against 67.26 in Burkina Faso, a difference of 1.75.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Cape Verde ahead.
Burkina Faso ranks 106th and Cape Verde ranks 105th of 146 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Cape Verde in 1.
Head to head by decade
| Decade | Burkina Faso | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 35.04 | 56.97 | 21.94 | Cape Verde |
| 2020s | 78.72 | 60 | 18.72 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Burkina Faso or Cape Verde?
- Cape Verde, at 69.01 against 67.26 in Burkina Faso as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Burkina Faso and Cape Verde?
- 1.75, with Cape Verde ahead.
- How many years of comparable data are there for Burkina Faso and Cape Verde?
- 5 years are reported by both, from 2017 to 2021.
- How do Burkina Faso and Cape Verde rank globally for the number of people with susceptibility test result for rifampicin?
- Burkina Faso ranks 106th and Cape Verde ranks 105th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.